Improving lung surgery precision with dye versus air technique
Part of Lungs & breathing clinical trials.
This trial compares two methods to help surgeons find the right section of the lung to remove during surgery. One method uses a special green dye, and the other uses air to inflate and deflate the lung. The goal is to find which is better at helping the surgeon remove only the sick part while saving healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are scheduled for lung surgery (thoracoscopic segmentectomy) to remove a part of your lung.
- You have a recent CT scan that shows the exact location of the problem area.
- Your surgery team has decided that removing only a segment of the lung is the right approach.
- You are willing to agree to participate by signing a consent form.
- You do not have a severe liver problem or allergy to indocyanine green (a dye used in the procedure)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a dye-based technique (using indocyanine green) to help surgeons identify lung segments during a lung cancer operation (segmentectomy). The goal is to improve how accurately and safely surgeons remove the affected part of the lung.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
This trial tests a new way to use a dye called ICG (indocyanine green) that is inhaled like a mist. It may help doctors see and treat congenital lung malformations in children more clearly.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This trial tests a new method using 3D virtual reality and a special dye (indocyanine green) to help surgeons see and remove only the affected part of the lung, preserving healthy tissue. It is for people with early-stage lung cancer that is small and located in one section of the lung.
Hear when a new Pulmonary Nodule, Solitary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.